BackThalys Medical Technology Group Overview

Thalys Medical Technology Group Receivables

Thalys Medical Technology Group's receivables is $630M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$628.91M
↓ 33.51% YoYΔ $-316.92M vs prior year quarter

Peer trimmed avg / median

Loading

Thalys Medical Technology Group Receivables History

Loading

Thalys Medical Technology Group vs. peers: Receivables Comparison

Loading

Thalys Medical Technology Group Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Thalys Medical Technology Group (603716.SS) FAQ

The latest receivables for 603716.SS is $630M as of September 2026. That compares with $950M in the prior-year period — down 33.5% year over year. Investors often review this figure alongside Thalys Medical Technology Group's historical trend and sector peers before judging valuation or financial health.

Over the past year, 603716.SS's receivables moved from $950M to $630M — a 33.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Thalys Medical Technology Group's operating scale or balance-sheet position.

A receivables figure of $630M for 603716.SS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 603716.SS's receivables ($630M), review year-over-year change from $950M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.